Insider Stock Trading History of Bosley Katrine


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Bosley Katrine since year 2005. The trader's CIK number is 1592469. At the time of this reporting, Bosley Katrine is the President and CEO of Editas Medicine, Inc. . (stock ticker symbol EDIT). See this page for all insider trading activities at Editas Medicine, Inc. .


Stock purchases, sales, and option exercises reported by insider Bosley Katrine since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2018-12-03 EDIT Editas Medicine, Inc. Sale 12,000 32.16 385,860
2018-11-01 EDIT Editas Medicine, Inc. Sale 12,000 26.62 319,440
2018-10-01 EDIT Editas Medicine, Inc. Sale 12,000 31.04 372,480
2018-09-04 EDIT Editas Medicine, Inc. Sale 12,000 32.67 392,040
2018-08-20 EDIT Editas Medicine, Inc. Sale 12,000 30.19 362,280
2018-08-01 EDIT Editas Medicine, Inc. Sale 8,333 29.74 247,823
2018-07-02 EDIT Editas Medicine, Inc. Sale 8,333 36.23 301,904
2018-06-01 EDIT Editas Medicine, Inc. Sale 8,333 38.52 321,028
2018-05-01 EDIT Editas Medicine, Inc. Sale 8,333 31.95 266,239
2018-04-02 EDIT Editas Medicine, Inc. Sale 8,333 32.22 268,489
2018-03-09 EDIT Editas Medicine, Inc. Sale 9,134 45.00 411,030
2018-03-01 EDIT Editas Medicine, Inc. Sale 8,333 35.63 296,904
2018-02-01 EDIT Editas Medicine, Inc. Sale 8,333 36.70 305,837
2018-01-29 EDIT Editas Medicine, Inc. Sale 10,000 37.53 375,340
2018-01-30 EDIT Editas Medicine, Inc. Sale 10,000 40.05 400,520
2018-01-23 EDIT Editas Medicine, Inc. Sale 3,338 35.28 117,764
2018-01-02 EDIT Editas Medicine, Inc. Sale 8,333 32.78 273,147
2018-01-03 EDIT Editas Medicine, Inc. Sale 6,662 35.04 233,416
2017-12-01 EDIT Editas Medicine, Inc. Sale 8,333 29.50 245,790
2017-11-01 EDIT Editas Medicine, Inc. Sale 8,333 24.22 201,858
2017-10-02 EDIT Editas Medicine, Inc. Sale 8,333 25.05 208,741
2017-09-01 EDIT Editas Medicine, Inc. Sale 10,000 20.80 207,970
2017-09-05 EDIT Editas Medicine, Inc. Sale 6,666 20.20 134,679
2017-08-10 EDIT Editas Medicine, Inc. Sale 10,000 20.02 200,159
2017-08-11 EDIT Editas Medicine, Inc. Sale 6,666 20.02 133,453

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Bosley Katrine (President and CEO of Editas Medicine, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.